Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Research Fine Foods & Pharmaceuticals N.T.M. S.p.A. (9S5) on Bullrun: valuation model: 2.8% overvalued, market cap EUR 194.94M, P/E 30.6, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker9S5
• ExchangeF
• CountryItaly
• SectorConsumer Defensive
• IndustryPackaged Foods
• CurrencyEUR
• Valuation signal2.8% overvalued
• Market capEUR 194.94M
• P/E30.6
• Dividend yield1.9%
• Financial periodFY2025
• RevenueEUR 253.46M
• Revenue growth3.4%
• Net incomeEUR 10.10M
• Free cash flow-EUR 2.87M

Valuation Snapshot

Bullrun's latest valuation model marks Fine Foods & Pharmaceuticals N.T.M. S.p.A. as 2.8% overvalued; latest market cap is EUR 194.94M; P/E is 30.6; dividend yield is 1.9%.

About Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries in Italy.

Frequently asked questions

Is Fine Foods & Pharmaceuticals N.T.M. S.p.A. overvalued or undervalued?

Bullrun's valuation model currently marks Fine Foods & Pharmaceuticals N.T.M. S.p.A. as 2.8% overvalued.

What is Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s market cap?

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s market capitalization is EUR 194.94M.

What is Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s P/E ratio?

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s price-to-earnings (P/E) ratio is 30.6.

Does Fine Foods & Pharmaceuticals N.T.M. S.p.A. pay a dividend?

Fine Foods & Pharmaceuticals N.T.M. S.p.A. has a dividend yield of 1.9%.

What does Fine Foods & Pharmaceuticals N.T.M. S.p.A. do?

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries in Italy.